Universal Health Services to Acquire Foundations Recovery Network
|
By HospiMedica International staff writers Posted on 30 Sep 2015 |
Hospital operator Universal Health Services (UHS; King of Prussia, PA, USA) has entered an agreement to buy addiction treatment provider Foundations Recovery Network (FRN; Brentwood, TN, USA) for USD 350 million.
Founded in 1995, FRN is a leader in addiction treatment and focused on treating adults with addiction and mental health disorders through an evidence-based integrated treatment model in residential and outpatient settings. The company operates a direct-to-consumer marketing model, which includes a call center, a US national sales team, and a web marketing program. The acquisition will serve as a platform for growth in a new substance use disorder service line for UHS, adding 322 residential beds in four facilities and eight outpatient centers, with a further 140 beds in the pipeline under a scheduled expansion.
UHS is one of the largest hospital companies in the United States. The company has several subsidiaries, including a behavioral health division that operates 195 facilities in 37 US states, as well as in Washington DC, Puerto Rico, the US Virgin Islands, and the United Kingdom providing comprehensive inpatient and outpatient mental health and substance abuse services, as well as a number of specialist programs for eating disorders, trauma, autism spectrum disorders, and neuropsychiatry services. It also operates an acute care division, providing medical and surgical services in 25 facilities.
“We are pleased to announce the forthcoming acquisition of Foundations. We were attracted to their proven track record of providing high-quality treatment and reputation for excellence in this very attractive market segment,” said Alan Miller, board chairman of UHS. “They bring expertise as a published authority on integrated treatment and also have excellent clinical programs and customer relationships.”
“Demand for evidence-based, high quality substance-use disorders is driving the immediate need for additional services nationwide. With access to UHS’s broad market presence, we hope to ramp our pace of growth exponentially” said Rob Waggener, CEO of FRN. “We expect to complete this transaction within the coming weeks.”
In 2014 UHS also purchased Cygnet Health Care, adding 17 facilities in the United Kingdom, which include 15 inpatient behavioral health hospitals and two nursing homes.
Related Links:
Universal Health Services
Foundations Recovery Network
Founded in 1995, FRN is a leader in addiction treatment and focused on treating adults with addiction and mental health disorders through an evidence-based integrated treatment model in residential and outpatient settings. The company operates a direct-to-consumer marketing model, which includes a call center, a US national sales team, and a web marketing program. The acquisition will serve as a platform for growth in a new substance use disorder service line for UHS, adding 322 residential beds in four facilities and eight outpatient centers, with a further 140 beds in the pipeline under a scheduled expansion.
UHS is one of the largest hospital companies in the United States. The company has several subsidiaries, including a behavioral health division that operates 195 facilities in 37 US states, as well as in Washington DC, Puerto Rico, the US Virgin Islands, and the United Kingdom providing comprehensive inpatient and outpatient mental health and substance abuse services, as well as a number of specialist programs for eating disorders, trauma, autism spectrum disorders, and neuropsychiatry services. It also operates an acute care division, providing medical and surgical services in 25 facilities.
“We are pleased to announce the forthcoming acquisition of Foundations. We were attracted to their proven track record of providing high-quality treatment and reputation for excellence in this very attractive market segment,” said Alan Miller, board chairman of UHS. “They bring expertise as a published authority on integrated treatment and also have excellent clinical programs and customer relationships.”
“Demand for evidence-based, high quality substance-use disorders is driving the immediate need for additional services nationwide. With access to UHS’s broad market presence, we hope to ramp our pace of growth exponentially” said Rob Waggener, CEO of FRN. “We expect to complete this transaction within the coming weeks.”
In 2014 UHS also purchased Cygnet Health Care, adding 17 facilities in the United Kingdom, which include 15 inpatient behavioral health hospitals and two nursing homes.
Related Links:
Universal Health Services
Foundations Recovery Network
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







